Literature DB >> 26459788

Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature.

Charis Bourgioti1, Konstantinos Chatoupis2, Alexandros Rodolakis3, Aristeidis Antoniou4, Chara Tzavara5, Vassilis Koutoulidis6, Lia Angela Moulopoulos7.   

Abstract

This is to evaluate the predictive ability of clinical examination and preoperative magnetic resonance imaging (MRI) for the staging of early cervical cancer. We prospectively evaluated 115 patients with cervical cancer, International Federation of Gynecologic and Obstetrics (FIGO) stage <IIB; receiver operating characteristic (ROC) analysis determined the predictive ability of MRI, clinical assessment, and their combination for tumor staging. Surgery was the standard of reference. MRI was more accurate than clinical examination for tumor estimate, parametrial or internal os involvement. When combined with MRI, the predictive ability of clinical examination for overall staging [area under the curve (AUC)=0.59, P>.05) increased significantly (AUC=0.84, P<.05). Our results support the official incorporation of MRI into FIGO classification system.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Cervix uteri; Magnetic resonance imaging; tumor staging

Mesh:

Year:  2015        PMID: 26459788     DOI: 10.1016/j.clinimag.2015.09.012

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  9 in total

Review 1.  Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016.

Authors:  Sungmin Woo; Chong Hyun Suh; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

2.  Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.

Authors:  Koji Matsuo; Muneaki Shimada; Keiichiro Nakamura; Yuji Takei; Kimio Ushijima; Toshiyuki Sumi; Tatsuru Ohara; Hideaki Yahata; Mikio Mikami; Toru Sugiyama
Journal:  Eur J Surg Oncol       Date:  2019-02-18       Impact factor: 4.424

Review 3.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

Review 4.  PET/MRI: Where might it replace PET/CT?

Authors:  Eric C Ehman; Geoffrey B Johnson; Javier E Villanueva-Meyer; Soonmee Cha; Andrew Palmera Leynes; Peder Eric Zufall Larson; Thomas A Hope
Journal:  J Magn Reson Imaging       Date:  2017-03-30       Impact factor: 4.813

5.  What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

Authors:  Njål Lura; Kari S Wagner-Larsen; David Forsse; Jone Trovik; Mari K Halle; Bjørn I Bertelsen; Øyvind Salvesen; Kathrine Woie; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Insights Imaging       Date:  2022-06-17

6.  The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.

Authors:  Zachary J Ward; Surbhi Grover; Andrew M Scott; Sungmin Woo; Dina H Salama; Elizabeth C Jones; Tarek El-Diasty; Bradley R Pieters; Edward L Trimble; H Alberto Vargas; Hedvig Hricak; Rifat Atun
Journal:  Lancet Oncol       Date:  2020-08       Impact factor: 41.316

Review 7.  The Complementary Role of Imaging and Tumor Biomarkerszzm321990in Gynecological Cancers: An Update of the Literature

Authors:  Emanuela Anastasi; Silvia Gigli; Laura Ballesio; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26

8.  Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging.

Authors:  Shruti Jolly; Shitanshu Uppal; Neerja Bhatla; Carolyn Johnston; Katherine Maturen
Journal:  J Glob Oncol       Date:  2017-03-21

9.  Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer.

Authors:  Kari S Wagner-Larsen; Njål Lura; Øyvind Salvesen; Mari Kyllesø Halle; David Forsse; Jone Trovik; Noeska Smit; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Eur Radiol       Date:  2022-03-24       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.